NCT04474678
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 6 Years to 14 Years (Child)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients unable to speak German
https://ClinicalTrials.gov/show/NCT04474678